Evidence map›Paper›PMID 30068357›Full record

ArticleJournal of neuroinflammation2018

Chronic Toxoplasma infection is associated with distinct alterations in the synaptic protein composition.

Daniel Lang, Björn H Schott, Marco van Ham, Lorena Morton, Leonora Kulikovskaja, Rodrigo Herrera-Molina, Rainer Pielot, Frank Klawonn, Dirk Montag, Lothar Jänsch and 3 more

Open access · goldAbstract read
In one paragraph

Article in Journal of neuroinflammation, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
7.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 91 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. iScience · 2026
    Article
  5. Article
  6. Article
  7. Frontiers in cellular and infection microbiology · 2025
    Review
  8. Article
  9. mFrontiers in cell and developmental biology · 2024
    Review
  10. Toxoplasma-induced behavior changes - is microbial dysbiosis the missing link?Frontiers in cellular and infection microbiology · 2024
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 2 countries.

Daniel LangInstitute of Inflammation and Neurodegeneration, Otto von Guericke University Magdeburg, Magdeburg, Germany.
Björn H SchottLeibniz Institute for Neurobiology, Magdeburg, Germany.
Marco van HamHelmholtz Centre for Infection Research, Cellular Proteomics Group, Braunschweig, Germany.
Lorena MortonInstitute of Inflammation and Neurodegeneration, Otto von Guericke University Magdeburg, Magdeburg, Germany.
Leonora KulikovskajaInstitute of Inflammation and Neurodegeneration, Otto von Guericke University Magdeburg, Magdeburg, Germany.
Rodrigo Herrera-MolinaLeibniz Institute for Neurobiology, Magdeburg, Germany.
Rainer PielotLeibniz Institute for Neurobiology, Magdeburg, Germany.
Frank KlawonnHelmholtz Centre for Infection Research, Cellular Proteomics Group, Braunschweig, Germany.
Dirk MontagLeibniz Institute for Neurobiology, Magdeburg, Germany.
Lothar JänschHelmholtz Centre for Infection Research, Cellular Proteomics Group, Braunschweig, Germany.
Eckart D GundelfingerLeibniz Institute for Neurobiology, Magdeburg, Germany.
Karl Heinz SmallaLeibniz Institute for Neurobiology, Magdeburg, Germany.
Ildiko Rita DunayInstitute of Inflammation and Neurodegeneration, Otto von Guericke University Magdeburg, Magdeburg, Germany. Ildikodunay@gmail.com.
Center for Behavioral Brain Sciences · DELeibniz Institute for Neurobiology · DEOtto-von-Guericke University Magdeburg · DEHelmholtz Centre for Infection Research · DEOstfalia University of Applied Sciences · DEUniversidad Bernardo O'Higgins · CL

Funding

DGF SFB854
6 · The paper itself

Abstract

backgroundChronic infection with the neurotropic parasite Toxoplasma gondii has been implicated in the risk for several neuropsychiatric disorders. The mechanisms, by which the parasite may alter neural function and behavior of the host, are not yet understood completely.

methodsHere, a novel proteomic approach using mass spectrometry was employed to investigate the alterations in synaptic protein composition in a murine model of chronic toxoplasmosis. In a candidate-based strategy, immunoblot analysis and immunohistochemistry were applied to investigate the expression levels of key synaptic proteins in glutamatergic signaling.

resultsA comparison of the synaptosomal protein composition revealed distinct changes upon infection, with multiple proteins such as EAAT2, Shank3, AMPA receptor, and NMDA receptor subunits being downregulated, whereas inflammation-related proteins showed an upregulation. Treatment with the antiparasitic agent sulfadiazine strongly reduced tachyzoite levels and diminished neuroinflammatory mediators. However, in both conditions, a significant number of latent cysts persisted in the brain. Conversely, infection-related alterations of key synaptic protein levels could be partly reversed by the treatment.

conclusionThese results provide evidence for profound changes especially in synaptic protein composition in T. gondii-infected mice with a downregulation of pivotal components of glutamatergic neurotransmission. Our results suggest that the detected synaptic alterations are a consequence of the distinct neuroinflammatory milieu caused by the neurotropic parasite.

Indexed as

AnimalsAntiprotozoal AgentsBrainChronic DiseaseCytokinesDisease Models, AnimalGene Expression RegulationGlutamic AcidMass SpectrometryMembrane ProteinsMeta-Analysis as TopicMiceNerve Tissue ProteinsProteomicsRNA, MessengerSulfadiazineAntiprotozoal AgentsCytokinesGlutamic AcidMembrane ProteinsNerve Tissue ProteinsRNA, MessengerSulfadiazineChronic Toxoplasma infectionNeuroinflammationSynaptic proteinsToxoplasma gondii

Identifiers

PMID30068357
PMCPMC6090988
OpenAlexW2885616839

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.